NSC243928 Treatment Induces Anti-Tumor Immune Response in Mouse Mammary Tumor Models
NSC243928 induces cell death in triple-negative breast cancer cells in a LY6K-dependent manner. NSC243928 has been reported as an anti-cancer agent in the NCI small molecule library. The molecular mechanism of NSC243928 as an anti-cancer agent in the treatment of tumor growth in the syngeneic mouse...
Main Authors: | Benson Chellakkan Selvanesan, Alvaro de Mingo Pulido, Sheelu Varghese, Deepak Rohila, Daniel Hupalo, Yuriy Gusev, Sara Contente, Matthew D. Wilkerson, Clifton L. Dalgard, Geeta Upadhyay |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/5/1468 |
Similar Items
-
Small Molecule Binds with Lymphocyte Antigen 6K to Induce Cancer Cell Death
by: Senyi Benti, et al.
Published: (2020-02-01) -
RIOK2 Inhibitor NSC139021 Exerts Anti-Tumor Effects on Glioblastoma via Inducing Skp2-Mediated Cell Cycle Arrest and Apoptosis
by: Min Yu, et al.
Published: (2021-09-01) -
NKT cell networks in the regulation of tumor immunity
by: Faith C Robertson, et al.
Published: (2014-10-01) -
Experimental and Computational Studies Reveal Novel Interaction of Lymphocytes Antigen 6K to TGF-β Receptor Complex
by: Justyna Andrys-Olek, et al.
Published: (2023-08-01) -
Signatures in in vitro infection of NSC-34 mouse neurons and their cell nucleus with Rickettsia helvetica
by: Lena Kask, et al.
Published: (2023-04-01)